HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicity
Giulia Tebaldi(University of Pennsylvania), Harvey M. Friedman(University of Pennsylvania), Kevin P. Egan(University of Pennsylvania), Kerry S. Campbell(Fox Chase Cancer Center), Lauren M. Hook(University of Pennsylvania), Tomas Bergström(Sahlgrenska University Hospital), Gary H. Cohen(University of Pennsylvania), Tina M. Cairns(University of Pennsylvania)
Cited by 0
Related Papers
Bone histomorphometry using free and commonly available software
|Histopathology|2012|131
Circulating Osteogenic Precursor Cells in Heterotopic Bone Formation
|Stem Cells|2009|127
Immunological control of herpes simplex virus infections
|Journal of NeuroVirology|2013|121
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
|PLoS Pathogens|2020|65
Role for Circulating Osteogenic Precursor Cells in Aortic Valvular Disease
|Arteriosclerosis Thrombosis and Vascular Biology|2011|64